Obtaining of monoclonal antibodies by means of DNA immunization. 2001

A Y Surovoi, and E A Sukhacheva, and M Y Wert, and F O Yarovinsky, and E S Zeinalova, and F Gaunitz, and E Uberahm, and R Gebhardt
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, Moscow, 117871 Russia.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005696 Galactosidases A family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage. EC 3.2.1.-. Galactosidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Y Surovoi, and E A Sukhacheva, and M Y Wert, and F O Yarovinsky, and E S Zeinalova, and F Gaunitz, and E Uberahm, and R Gebhardt
April 2003, Journal of virological methods,
A Y Surovoi, and E A Sukhacheva, and M Y Wert, and F O Yarovinsky, and E S Zeinalova, and F Gaunitz, and E Uberahm, and R Gebhardt
January 1984, Wiadomosci parazytologiczne,
A Y Surovoi, and E A Sukhacheva, and M Y Wert, and F O Yarovinsky, and E S Zeinalova, and F Gaunitz, and E Uberahm, and R Gebhardt
April 1994, BioTechniques,
A Y Surovoi, and E A Sukhacheva, and M Y Wert, and F O Yarovinsky, and E S Zeinalova, and F Gaunitz, and E Uberahm, and R Gebhardt
October 2013, Human vaccines & immunotherapeutics,
A Y Surovoi, and E A Sukhacheva, and M Y Wert, and F O Yarovinsky, and E S Zeinalova, and F Gaunitz, and E Uberahm, and R Gebhardt
August 2009, Hybridoma (2005),
A Y Surovoi, and E A Sukhacheva, and M Y Wert, and F O Yarovinsky, and E S Zeinalova, and F Gaunitz, and E Uberahm, and R Gebhardt
January 2003, Methods in molecular biology (Clifton, N.J.),
A Y Surovoi, and E A Sukhacheva, and M Y Wert, and F O Yarovinsky, and E S Zeinalova, and F Gaunitz, and E Uberahm, and R Gebhardt
January 1985, Salud publica de Mexico,
A Y Surovoi, and E A Sukhacheva, and M Y Wert, and F O Yarovinsky, and E S Zeinalova, and F Gaunitz, and E Uberahm, and R Gebhardt
January 1992, Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M,
A Y Surovoi, and E A Sukhacheva, and M Y Wert, and F O Yarovinsky, and E S Zeinalova, and F Gaunitz, and E Uberahm, and R Gebhardt
July 2009, Immunology and cell biology,
A Y Surovoi, and E A Sukhacheva, and M Y Wert, and F O Yarovinsky, and E S Zeinalova, and F Gaunitz, and E Uberahm, and R Gebhardt
October 1991, Hybridoma,
Copied contents to your clipboard!